Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation platforms. This includes U.S. Food and Drug ...
Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.
The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation ...
The new regulatory approvals expand Medtronic’s mapping and tissue-proximity capabilities for cardiac ablation.
Software mapping is the practice of diagramming and visualizing the intricacies and dependencies within a software system. It gives a bird's eye view of the software's structure, helping developers ...
Wednesday, Medtronic plc said it received FDA clearance and CE Mark for the latest Affera Prism-2 Mapping Software and CE Mark for the PulseSelect ProxBox Adapter with Proximity I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results